Citadel Advisors
GTHX

Citadel Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-239
Closed -$545 6972
2024
Q2
$545 Buy
239
+227
+1,892% +$518 ﹤0.01% 5744
2024
Q1
$52 Sell
12
-43,954
-100% -$190K ﹤0.01% 6028
2023
Q4
$134K Sell
43,966
-96,852
-69% -$295K ﹤0.01% 4778
2023
Q3
$203K Sell
140,818
-1,090
-0.8% -$1.57K ﹤0.01% 4543
2023
Q2
$353K Buy
141,908
+40,145
+39% +$100K ﹤0.01% 3955
2023
Q1
$273K Sell
101,763
-193,160
-65% -$518K ﹤0.01% 4367
2022
Q4
$1.6M Buy
294,923
+193,835
+192% +$1.05M ﹤0.01% 2772
2022
Q3
$1.26M Sell
101,088
-230,806
-70% -$2.88M ﹤0.01% 3180
2022
Q2
$1.64M Buy
331,894
+38,858
+13% +$192K ﹤0.01% 2932
2022
Q1
$2.23M Buy
293,036
+25,631
+10% +$195K ﹤0.01% 2894
2021
Q4
$2.73M Buy
267,405
+247,871
+1,269% +$2.53M ﹤0.01% 2709
2021
Q3
$262K Sell
19,534
-22,588
-54% -$303K ﹤0.01% 5144
2021
Q2
$924K Sell
42,122
-34,254
-45% -$751K ﹤0.01% 4107
2021
Q1
$1.84M Sell
76,376
-102,004
-57% -$2.45M ﹤0.01% 3247
2020
Q4
$3.21M Sell
178,380
-82,384
-32% -$1.48M ﹤0.01% 2146
2020
Q3
$3.01M Buy
260,764
+180,673
+226% +$2.09M ﹤0.01% 1920
2020
Q2
$1.94M Sell
80,091
-45,178
-36% -$1.1M ﹤0.01% 2279
2020
Q1
$1.38M Sell
125,269
-4,107
-3% -$45.3K ﹤0.01% 2567
2019
Q4
$3.42M Buy
129,376
+111,852
+638% +$2.96M ﹤0.01% 1915
2019
Q3
$400K Sell
17,524
-5,572
-24% -$127K ﹤0.01% 3649
2019
Q2
$708K Sell
23,096
-255,412
-92% -$7.83M ﹤0.01% 3253
2019
Q1
$4.62M Buy
278,508
+106,653
+62% +$1.77M ﹤0.01% 1638
2018
Q4
$3.29M Buy
171,855
+167,210
+3,600% +$3.2M ﹤0.01% 1803
2018
Q3
$243K Buy
+4,645
New +$243K ﹤0.01% 3626
2018
Q2
Sell
-8,324
Closed -$308K 4670
2018
Q1
$308K Buy
+8,324
New +$308K ﹤0.01% 3241